Search company, investor...
InforSense company logo


Founded Year



Acquired | Acquired

Total Raised


About InforSense

InforSens provides integrative analytics and enables organizations to orchestrate and optimize their business-critical decision-making processes. Leading pharmaceutical and biotechnology, consumer goods, financial services companies, and research institutes are using the company's flagship product, InforSense KDE, to enhance productivity across life science R&D, healthcare, and business analytics. The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts.

Headquarters Location

Colet Court 100 Hammersmith Road

London, England, W6 7JP,

United Kingdom

Missing: InforSense's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: InforSense's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest InforSense News

IDBS Acquires InforSense in UK Software Merger - Bio-IT World

Oct 28, 2015

IDBS Acquires InforSense in UK Software Merger By Bio-IT World staff June 25, 2009 | “This is an exciting day in the history of InforSense,” said CEO David Bennett, in announcing that the British firm is being acquired by ID Business Solutions (IDBS), another privately held, profitable British software company. IDBS is the larger of the two organizations, and provides a series of secure and searchable data management solutions in many industries, including but not limited to life sciences. IDBS is a past recipient of the Queen's Award for Enterprise and Innovation. Bennett says that the acquisition is “very good news for our customers,” in that it provides them with enhanced sales and R&D support, while maintaining the InforSense brand name and product lines. The merger with IDBS will provide access to a broader portfolio of data management products. Bennett says “IDBS is now the first organization in the R&D sector to provide the entire spectrum of products for data capture, storage, integration, retrieval, analysis, and visualization.”  Bennett adds: “There is great synergy with InforSense, not only in the product lines but in our overall philosophies of product quality, business ethics and customer support… Our goal is to build on this synergy to make the products even more compatible, for the maximum benefit to all of our R&D customers.” IDBS provides data management solutions in the collection of contextual data. Its key products for the biology and chemistry markets include the E-Workbook suite, ActivityBase, and Decision Support. InforSense's rapid data integration technologies and Web-based interactive analytics should complement IDBS’ secure, context-rich data management solutions. The sale to IDBS comes just six months after  InforSense founder Yike Guo stepped down as CEO and assumed the role of chief technology officer and head of innovation. Guo will now assume the role of Chief Innovation Officer at IDBS. John O’Connell, Chairman of InforSense, said he was “delighted to see InforSense become part of a visionary software company with proven expertise in the life sciences domain. The market can only react positively to the emergence of the first single end-to-end R&D informatics solution provider.” Neil Kipling, CEO and founder of IDBS, said his firm’s existing domain expertise and 20-year track record would be enhanced by InforSense acquisition. “This is a major enabling step towards becoming the number one informatics partner of R&D worldwide. An additional facet of this acquisition is the opportunity to cement a strategic informatics research relationship with Imperial College. The combination of our rigorous software development and powerful new research capabilities creates a groundbreaking new organization.” IDBS says it will expand its large scale data integration activities to support international data sharing and broaden its life sciences portfolio into areas such as biomarker development and personalized medicine. IDBS has also announced a separate deal to provide data sharing solutions to the Department of Chemistry at the Univesrsity of Cambridge -– the start of an ongoing informatics collaboration that will provide leading-edge technologies for commercialization. Bennett says the InforSense technology and market momentum were key factors in attracting the offer from IDBS. Work on integrating the companies will be spelled out in the coming months. View Next Related Story

InforSense Frequently Asked Questions (FAQ)

  • When was InforSense founded?

    InforSense was founded in 1999.

  • Where is InforSense's headquarters?

    InforSense's headquarters is located at Colet Court, London.

  • What is InforSense's latest funding round?

    InforSense's latest funding round is Acquired.

  • How much did InforSense raise?

    InforSense raised a total of $10M.

  • Who are the investors of InforSense?

    Investors of InforSense include ID Business Solutions, Touchstone Innovations, Elaia Partners, Stonehage Fleming, Sitka Capital and 5 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.